![Daniel Mansuri](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Oorsprong van het eerstegraads netwerk van Daniel Mansuri
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
Sanofi Ventures
![]() Sanofi Ventures Investment ManagersFinance Sanofi Ventures (Sanofi) is a venture capital subsidiary of Sanofi founded in 2001. The firm is headquartered in Cambridge, Massachusetts.
4
| Subsidiary | Investment Managers | 4 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Daniel Mansuri via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
TRANSGENE | Biotechnology | Director of Finance/CFO | |
Click Therapeutics, Inc.
![]() Click Therapeutics, Inc. Packaged SoftwareTechnology Services Click Therapeutics, Inc. develops and commercializes software as prescription medical treatments for people with unmet medical needs. The company is headquartered in New York, NY. | Packaged Software | Private Equity Investor | |
Novo Holdings AS (Denmark)
![]() Novo Holdings AS (Denmark) Financial ConglomeratesFinance Novo Holding A/S provides financial investments and manages the Novo Nordisk Foundation?s assets. It offers seed and venture capital to development stage companies and takes ownership positions in companies within life science and biotechnology. The company was founded on September 8, 1999 and is headquartered in Hellerup, Denmark. | Financial Conglomerates | Private Equity Investor | |
Boston University | College/University | Graduate Degree | |
Arthur Andersen LLP
![]() Arthur Andersen LLP Miscellaneous Commercial ServicesCommercial Services Arthur Andersen LLP used to provide accounting services. It was also into consulting services for clients that operate businesses throughout the United States and around the world. Arthur Andersen was founded in 1913 and was headquartered in Chicago, IL. | Miscellaneous Commercial Services | Comptroller/Controller/Auditor | |
Therini Bio, Inc.
![]() Therini Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Therini Bio, Inc. engages in research and development in the field of biotechnology. The company was founded by Katerina Akassoglou in 2016 and is headquartered in San Francisco, CA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Neurotech Pharmaceuticals, Inc. (United States)
![]() Neurotech Pharmaceuticals, Inc. (United States) Pharmaceuticals: MajorHealth Technology Neurotech Pharmaceuticals, Inc. designs and develops therapeutic systems for retinal diseases. The company was founded in 1995 and is headquartered in Cumberland, RI. | Pharmaceuticals: Major | Chief Executive Officer | |
Glycomine, Inc.
![]() Glycomine, Inc. BiotechnologyHealth Technology Glycomine, Inc. engages in the development of therapeutics for diseases which have no treatment options. Its therapeutic approach is to combine replacement therapies such as substrates, enzymes, or proteins with intracellular delivery vehicles consisting of bio-nanomaterials or ligands that target the molecules to the cell interior of clinically relevant organs. It focuses on research of mannose-1-phosphate and Ngly1 enzyme replacement therapy, and observational study of GLY-000. The company was founded in 2014 by Agnes Rafalko and is headquartered in San Carlos, CA. | Biotechnology | Director/Board Member | |
Muna Therapeutics ApS
![]() Muna Therapeutics ApS Medical/Nursing ServicesHealth Services Muna Therapeutics ApS is a Danish private biopharmaceutical company that discovers and develops therapies to slow or stop neurodegenerative diseases such as Alzheimer's, frontotemporal dementia, and Parkinson's. Muna Therapeutics is based in Copenhagen, DK and was founded in 2020 by Simon Glerup and Bart de Strooper. The company focuses on identifying new medicines to preserve cognition and other brain functions and enhance resilience to these diseases. Rita Balice-Gordon has been the CEO of the company since 2020. | Medical/Nursing Services | Director/Board Member | |
QurAlis Corp.
![]() QurAlis Corp. Pharmaceuticals: MajorHealth Technology QurAlis Corp. engages in discovering and developing new therapies for amyotrophic lateral sclerosis and other neurological diseases. It offers therapeutic programs and targets, and biomarkers. The company was founded by Clifford Woolf, Kevin Eggan, Jonathan J. Fleming, and Kasper Roet and is headquartered in North Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member | |
Pivotal Bioventure Partners Investment Advisor LLC
![]() Pivotal Bioventure Partners Investment Advisor LLC Investment ManagersFinance Pivotal Bioventure Partners Investment Advisor LLC (Pivotal Bioventure) is a venture capital firm founded in 2017 by Vincent Cheung. The firm is headquartered in San Francisco, California. | Investment Managers | Private Equity Investor | |
University of Michigan | College/University | Undergraduate Degree | |
Massachusetts Institute of Technology | College/University | Doctorate Degree | |
Veralox Therapeutics, Inc.
![]() Veralox Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Veralox Therapeutics, Inc. develops small molecule therapeutics that treat the underlying pathologies of thrombosis and type 1 diabetes. The company was founded by Jeffrey W. Strovel, David J. Maloney and Matthew B. Boxer and is headquartered in Frederick, MD. | Pharmaceuticals: Major | Director/Board Member | |
Haas School of Business | College/University | Masters Business Admin | |
Cambridge Judge Business School | College/University | Masters Business Admin | |
Rome Therapeutics, Inc.
![]() Rome Therapeutics, Inc. BiotechnologyHealth Technology Rome Therapeutics, Inc. develops novel therapies for cancer and autoimmune diseases by harnessing the power of the repeatome-vast stretches of uncharted genetic materials. The company was founded by Rosana Kapeller and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
Suffolk University | College/University | Undergraduate Degree | |
MediSafe, Inc.
![]() MediSafe, Inc. Hospital/Nursing ManagementHealth Services MediSafe, Inc. develops a cloud-synced mobile medication management system. The firm is a cloud-based application that monitors an individual's medicine intake to prevent potentially fatal incidences of under-dosing or overdosing. It helps address the global issue of medication non-adherence. The company was founded in August 2012 by Rotem Shor and Omri Shor and is headquartered in Nofit, Israel. | Hospital/Nursing Management | Director/Board Member | |
Science 37, Inc.
![]() Science 37, Inc. BiotechnologyHealth Technology Science 37, Inc. develops mobile technology, clinical trials and patient-centric models for clinical research. It focuses on the development of networked patient-centric models for clinical research to accelerate biomedical discovery. The firm develops Network Oriented Research Assistant, which bridges the gap between traditional trial management software and an advanced telemedicine platform; supports end-to-end management of networked clinical trials; and allows researchers to communicate with patients and mobile nurses from homes using videos, photographs, survey forms, or device data capture on iPhones, iPads, or Android devices. The company was founded by Noah Craft and Belinda Tan and is headquartered in Culver City, CA. | Biotechnology | Private Equity Investor | |
OxThera AB
![]() OxThera AB Pharmaceuticals: GenericHealth Technology OxThera AB develops pharmaceutical products for treatment of hyperoxaluria. Its intellectual property includes worldwide patents for compositions and treatment of hyperoxaluria with bacteria and enzymes. The firm?s products in pipeline include Oxabact, for the treatment of primary hyperoxaluria and oxazyme for the prevention of oxalate malabsorption and recurring kidney stones in secondary hyperoxaluria. The company was founded in 2005 and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Generic | Director/Board Member | |
University of Barcelona | College/University | Doctorate Degree | |
Omega Fund Management LLC
![]() Omega Fund Management LLC Investment ManagersFinance Omega Fund Management Ltd. (OFM) is the wholly-owned private equity firm founded by Dr. Otello Stampacchia in 2004. The firm is headquartered in the US. | Investment Managers | Private Equity Investor | |
Sanofi Pasteur
![]() Sanofi Pasteur BiotechnologyHealth Technology Sanofi Pasteur SA develops, manufactures and supplies vaccines. It provides vaccines for bacterial and viral diseases, including diphtheria, typhoid fever, and poliomyelitis. The company was founded in 1990 and is headquartered in Lyon, France. | Biotechnology | Director of Finance/CFO | |
The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin | |
EM Lyon Business School | College/University | Graduate Degree | |
KAHR Medical Ltd.
![]() KAHR Medical Ltd. Pharmaceuticals: MajorHealth Technology KAHR Medical Ltd. develops novel fusion protein pharmaceuticals for the treatment of cancer and autoimmune diseases. Its drug pipeline is built around the signal converter proteins a unique class of multi-functional therapeutic agents that convert signals sent from one cell to another. The firm?s therapeutic proteins integrate two functional units, enabling each one to elicit multiple cooperative functional endpoints. The company was founded by Mark L. Tykocinski in 2005 and is headquartered in Jerusalem, Israel. | Pharmaceuticals: Major | Director/Board Member | |
Endeavor BioMedicines, Inc
![]() Endeavor BioMedicines, Inc Miscellaneous Commercial ServicesCommercial Services Endeavor BioMedicines, Inc is a clinical stage company located in Solana Beach, CA, that develops novel therapies for fibrosis and oncology. The company's lead program, env-101, is a hedgehog signalling inhibitor currently in phase 2 studies treating IPF, a progressive interstitial lung disease that causes inflammation and scarring in the lung. The company's second program is a HER3-targeted ADC that will begin clinical development in 2024 for the treatment of multiple solid tumors. The company's mission is to develop transformative medicines by targeting the underlying genetic and cellular causes of disease with best in class agents. Endeavor is partnered with XCures and is currently looking at the LOF mutation. Regardless of eligibility for the Endeavor trial, XCures will still send a list of other treatment options that could work for the cancer mutation. The company was founded by Miguel A. de los Ríos and John Hood, with John Hood serving as the CEO since incorporation. | Miscellaneous Commercial Services | Director/Board Member | |
Minoryx Therapeutics SL
![]() Minoryx Therapeutics SL BiotechnologyHealth Technology Minoryx Therapeutics SL engages in the development of drugs for the orphan genetic diseases of the central nervous system. The company was founded by Marc Martinell, Joan Aymami, Nigel Ten Fleming and Xavier Barril in 2011 and is headquartered in Barcelona, Spain. | Biotechnology | Director/Board Member | |
LEXEO THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Upstream Bio, Inc.
![]() Upstream Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Upstream Bio, Inc. is a clinical-stage biopharmaceutical company based in Waltham, MA, USA. The American company's lead program, upb-101, is a monoclonal antibody that inhibits the TSLP receptor, a validated target that affects various immune cells involved in common and rare diseases. Upstream Bio is leveraging its diverse roots and substantial industry experience to develop therapies that ease the burden of inflammatory and allergic diseases on patients and their loved ones. The company was founded by Eran Perry and Earn Perry, and Samantha Truex has been the CEO since 2021. | Miscellaneous Commercial Services | Director/Board Member | |
Fortel Invest Oy
![]() Fortel Invest Oy Investment ManagersFinance Fortel Invest Oy (Fortel Invest) is a private equity subsidiary of Sipila Family founded in 1995 by Juha Sipila. The firm is headquartered in Oulu, Finland. | Investment Managers | Director of Finance/CFO | |
Ysios Capital Partners SGEIC SA
![]() Ysios Capital Partners SGEIC SA Investment ManagersFinance Ysios Capital Partners SGEIC SA (Ysios Capital) is a venture capital firm founded in 2007 by Joël Jean Pierre Jean-Mairet, Julia Salaverría Monfort and Josep Lluís Sanfeliu Benet. The firm is headquartered in San Sabastian, Spain with additional office in Barcelona. | Investment Managers | Investment Committee Member | |
Inbiomotion SL
![]() Inbiomotion SL Medical SpecialtiesHealth Technology Inbiomotion SL designs and develops diagnostic assays. It focus on genetic biomarkers, which predict the bone-specific metastases in cancer patients. The firm develops biomarker in breast cancer primary tumors for predicting the bone relapse. The company was founded by in 2010 and is headquartered in Barcelona, Spain. | Medical Specialties | Director/Board Member | |
Medisafe Project Ltd.
![]() Medisafe Project Ltd. Hospital/Nursing ManagementHealth Services Medisafe Project Ltd. develops a cloud-synced mobile medication management system. Its platform helps the user manage and take medication on time. The company was founded by Omri Shor and Rotem Shor in 2012 and is headquartered in Matam, Israel. | Hospital/Nursing Management | Private Equity Investor |
Statistieken
Internationaal
Verenigde Staten | 22 |
Frankrijk | 6 |
Spanje | 5 |
Israël | 4 |
Denemarken | 3 |
Sectoraal
Health Technology | 18 |
Consumer Services | 9 |
Finance | 7 |
Commercial Services | 5 |
Health Services | 4 |
Operationeel
Director/Board Member | 19 |
Private Equity Investor | 13 |
Director of Finance/CFO | 6 |
Masters Business Admin | 3 |
Chief Executive Officer | 2 |
Sterkste connecties
Insiders | |
---|---|
Bernard Davitian | 19 |
Laia Crespo | 10 |
Jim Trenkle | 10 |
Cris de Luca | 8 |
- Beurs
- Insiders
- Daniel Mansuri
- Bedrijfsconnecties